Overview

A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months

Status:
Completed
Trial end date:
2006-08-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the effects on vision of six months of daily dosing of 5 mg tadalafil or 50 mg sildenafil compared with placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
ICOS Corporation
Treatments:
Tadalafil